Cargando…
Antibody-based therapies for COVID-19: Can Europe move faster?
Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200003/ https://www.ncbi.nlm.nih.gov/pubmed/32369479 http://dx.doi.org/10.1371/journal.pmed.1003127 |
| _version_ | 1783529254239076352 |
|---|---|
| author | Kazatchkine, Michel D. Goldman, Michel Vincent, Jean-Louis |
| author_facet | Kazatchkine, Michel D. Goldman, Michel Vincent, Jean-Louis |
| author_sort | Kazatchkine, Michel D. |
| collection | PubMed |
| description | Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus. |
| format | Online Article Text |
| id | pubmed-7200003 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72000032020-05-12 Antibody-based therapies for COVID-19: Can Europe move faster? Kazatchkine, Michel D. Goldman, Michel Vincent, Jean-Louis PLoS Med Perspective Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus. Public Library of Science 2020-05-05 /pmc/articles/PMC7200003/ /pubmed/32369479 http://dx.doi.org/10.1371/journal.pmed.1003127 Text en © 2020 Kazatchkine et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Perspective Kazatchkine, Michel D. Goldman, Michel Vincent, Jean-Louis Antibody-based therapies for COVID-19: Can Europe move faster? |
| title | Antibody-based therapies for COVID-19: Can Europe move faster? |
| title_full | Antibody-based therapies for COVID-19: Can Europe move faster? |
| title_fullStr | Antibody-based therapies for COVID-19: Can Europe move faster? |
| title_full_unstemmed | Antibody-based therapies for COVID-19: Can Europe move faster? |
| title_short | Antibody-based therapies for COVID-19: Can Europe move faster? |
| title_sort | antibody-based therapies for covid-19: can europe move faster? |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200003/ https://www.ncbi.nlm.nih.gov/pubmed/32369479 http://dx.doi.org/10.1371/journal.pmed.1003127 |
| work_keys_str_mv | AT kazatchkinemicheld antibodybasedtherapiesforcovid19caneuropemovefaster AT goldmanmichel antibodybasedtherapiesforcovid19caneuropemovefaster AT vincentjeanlouis antibodybasedtherapiesforcovid19caneuropemovefaster |